Detalhe da pesquisa
1.
Impact of EU regulatory label changes for diclofenac in people with cardiovascular disease in four countries: Interrupted time series regression analysis.
Br J Clin Pharmacol
; 87(3): 1129-1140, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32668021
2.
Impact of EMA regulatory label changes on hydroxyzine initiation, discontinuation and switching to other medicines in Denmark, Scotland, England and the Netherlands: An interrupted time series regression analysis.
Pharmacoepidemiol Drug Saf
; 30(4): 482-491, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33386650
3.
Use of intravenous iron and risk of anaphylaxis: A multinational observational post-authorisation safety study in Europe.
Pharmacoepidemiol Drug Saf
; 30(10): 1447-1457, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34181291
4.
Impact of EMA regulatory label changes on systemic diclofenac initiation, discontinuation, and switching to other pain medicines in Scotland, England, Denmark, and The Netherlands.
Pharmacoepidemiol Drug Saf
; 29(3): 296-305, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31899936
5.
Increased risk of morbidities and health-care utilisation in children born following preterm labour compared with full-term labour: A population-based study.
J Paediatr Child Health
; 55(4): 446-453, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30288825
6.
No Evidence for an Association Between Renal Function and Serious Bleeding Events in Patients Treated With Coumarins: A Population-Based Study.
Ann Pharmacother
; 52(3): 221-234, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28985682
7.
Validation of safety outcomes in routinely collected data: Lessons learned from a multinational postapproval safety study.
Pharmacoepidemiol Drug Saf
; 32(5): 592-596, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36495188
8.
Thrombotic risk minimization for Diane-35 and generics.
Pharmacoepidemiol Drug Saf
; 26(11): 1411-1417, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28952198
9.
Sex differences in the intensity of statin prescriptions at initiation in a primary care setting.
Heart
; 2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38580433
10.
Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries.
PLoS One
; 19(3): e0298596, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38451960
11.
Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe.
BMJ Open
; 14(3): e081348, 2024 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38531587
12.
Time Trends in Patient Characteristics of New Rivaroxaban Users with Atrial Fibrillation in Germany and the Netherlands.
Drugs Real World Outcomes
; 10(2): 215-224, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36725812
13.
Safety and effectiveness of rivaroxaban for prevention of stroke in patients with nonvalvular atrial fibrillation: analysis of routine clinical data from four countries.
Expert Opin Drug Saf
; 22(6): 493-500, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36795067
14.
Methodology of the brodalumab assessment of hazards: a multicentre observational safety (BRAHMS) study.
BMJ Open
; 13(2): e066057, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36725094
15.
Increased Risk of Stroke Due to Non-adherence and Non-persistence with Direct Oral Anticoagulants (DOACs): Real-World Analyses Using a Nested Case-Control Study from The Netherlands, Italy and Germany.
Drugs Real World Outcomes
; 9(4): 597-607, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35790603
16.
Adherence and Persistence with Once-Daily vs Twice-Daily Direct Oral Anticoagulants Among Patients with Atrial Fibrillation: Real-World Analyses from the Netherlands, Italy and Germany.
Drugs Real World Outcomes
; 9(2): 199-209, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34993898
17.
Reduction in use of cyproterone/ethinylestradiol (Diane-35 and generics) after risk minimization measures in the Netherlands, UK and Italy.
Contraception
; 102(4): 243-245, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32470466
18.
Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries.
Clin Epidemiol
; 12: 423-433, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32431551
19.
Lead isotopic analysis of infant bone tissue dating from the Roman era via multicollector ICP-mass spectrometry.
Anal Bioanal Chem
; 390(2): 477-86, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17968533